41 – 50 of 117
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The impact of amyloid burden and APOE on rates of cognitive impairment in late life depression
- Contribution to journal › Article
-
Mark
Polyoxometalates as Effective Nano-inhibitors of Amyloid Aggregation of Pro-inflammatory S100A9 Protein Involved in Neurodegenerative Diseases
- Contribution to journal › Article
- 2020
-
Mark
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course - A joint PhD student course at University College London and University of Gothenburg
- Contribution to journal › Scientific review
-
Mark
Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors
(2020) In Proceedings of the National Academy of Sciences of the United States of America 117(39). p.24251-24257
- Contribution to journal › Article
-
Mark
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein
- Contribution to journal › Article
-
Mark
Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?
- Contribution to journal › Article
-
Mark
Amyloid-specific extraction using organic solvents
- Contribution to journal › Article
-
Mark
Kinetic diversity of amyloid oligomers
- Contribution to journal › Article
-
Mark
The properties of α-synuclein secondary nuclei are dominated by the solution conditions rather than the seed fibril strain
- Contribution to journal › Article
-
Mark
Secondary Nucleation in Amyloid Formation
(2020)
- Thesis › Doctoral thesis (compilation)
